Eli Lilly: has extended its tender offer for Point Biopharma
The tender offer, which was due to expire on November 16, 2023 at 5:00 p.m., has been extended to December 1, 2023 at 5:00 p.m., unless the tender offer is extended or terminated earlier, in order for the parties to satisfy the minimum tender condition.
All regulatory approvals required to complete the transaction have been obtained.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction